Study design (if review, criteria of inclusion for studies)
Interventional - Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
Participants
Exocrine Pancreatic Insufficiency (EPI)|Cystic Fibrosis (CF) - 18 Years and older (Adult, Older Adult)
Interventions
Drug: MS1819|Drug: Porcine PERT
Outcome measures
Safety of MS1819 by number of subjects reporting 1 or more adverse events|Efficacy of MS1819: Coefficient of fat absorption (CFA)|Stool weights|Signs and symptoms of malabsorption|Coefficient of Nitrogen Absorption (CNA)